Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Silk Road Medical Inc (SILK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Silk Road Medical's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
17.65 +0.08    +0.46%
25/04 - Closed. Currency in USD ( Disclaimer )
After Hours
17.65
0.00
0.00%
16:20:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 604,643
  • Bid/Ask: 15.97 / 18.00
  • Day's Range: 16.40 - 17.77
Silk Road Medical 17.65 +0.08 +0.46%

SILK Recent Sentiments

 
This page contains information on users’ sentiments for the Silk Road Medical Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 02, 2024 Diane Francois   14.87 Feb 05, 2024 @ 15.39 +3.50%
Jan 22, 2024 Yusif Abasalizada   14.95 Jan 22, 2024 @ 15.02 +0.47%
Nov 14, 2023 Robbert Kuipers   7.95 Dec 08, 2023 @ 9.72 +22.26%
Nov 13, 2023 Robbert Kuipers   7.73 Nov 14, 2023 @ 7.95 +2.85%
Nov 13, 2023 Robbert Kuipers   7.73 Nov 13, 2023 @ 7.73 0.00%
Nov 13, 2023 Robbert Kuipers   7.86 Nov 13, 2023 @ 7.75 -1.40%
Nov 13, 2023 Robbert Kuipers   8.00 Nov 13, 2023 @ 7.86 -1.75%
Nov 13, 2023 Robbert Kuipers   8.10 Nov 13, 2023 @ 8.00 -1.23%
Nov 13, 2023 Robbert Kuipers   8.10 Nov 13, 2023 @ 8.10 0.00%
Nov 13, 2023 Robbert Kuipers   8.10 Nov 13, 2023 @ 8.12 +0.25%
Nov 13, 2023 Robbert Kuipers   8.06 Nov 13, 2023 @ 8.12 +0.74%
Nov 13, 2023 Robbert Kuipers   8.07 Nov 13, 2023 @ 8.07 0.00%
Nov 13, 2023 Robbert Kuipers   8.07 Nov 13, 2023 @ 8.07 0.00%
Oct 13, 2023 Francesco Morfini   7.17 Nov 30, 2023 @ 8.63 +20.36%
Oct 12, 2023 Yavor Naydenov   7.16 Nov 30, 2023 @ 8.63 +20.53%
Oct 11, 2023 רונן בן   6.96 Nov 30, 2023 @ 8.63 +23.99%
Sep 14, 2023 Mena Trader   17.38 Nov 30, 2023 @ 8.63 -50.35%
Jul 26, 2023 nasser alsubaie   23.03 Nov 30, 2023 @ 8.63 +62.53%
Jul 24, 2023 Massimiliano Bari   20.11 Nov 30, 2023 @ 8.63 -57.09%
Jul 14, 2023 Salomon Ruiz Garcia   21.82 Aug 16, 2023 @ 20.27 -7.10%
Jul 13, 2023 Orkhan Hajiyev   22.33 Nov 30, 2023 @ 8.63 -61.35%
Jul 12, 2023 Arman Kala   23.65 Nov 30, 2023 @ 8.63 +63.51%
Jul 12, 2023 Roberto Campuzano   23.48 Jul 21, 2023 @ 20.04 -14.65%
Jul 12, 2023 Igor Sklarov   21.97 Sep 10, 2023 @ 18.60 +15.34%
Nov 09, 2022 Robbert Kuipers   46.34 Nov 14, 2022 @ 48.88 +5.48%
May 02, 2022 Karl Andersson   39.92 May 30, 2022 @ 32.35 -18.96%
Jul 30, 2021 רונן בן חמו   51.46 Aug 20, 2021 @ 48.78 -5.21%
May 05, 2021 Diane Francois   53.66 May 10, 2021 @ 50.33 -6.21%
May 05, 2021 Robbert Kuipers   53.94 May 10, 2021 @ 50.33 -6.69%
Mar 01, 2021 Diane Francois   57.63 Mar 26, 2021 @ 47.78 -17.09%
Feb 01, 2021 Oleg Smolkotin   54.01 Feb 26, 2021 @ 54.77 -1.41%
Jan 06, 2021 Oleg Smolkotin   57.98 Jan 29, 2021 @ 54.53 +5.95%
Nov 05, 2020 Ιωάννης Ιγνατιάδης   67.89 Nov 27, 2020 @ 57.50 -15.30%
Oct 22, 2020 Mark Wanner   61.66 Nov 13, 2020 @ 61.67 +0.02%
Sep 18, 2020 Building Future...   71.42 Oct 09, 2020 @ 66.44 -6.97%
Jul 27, 2020 土井 隆司   47.79 Aug 21, 2020 @ 54.16 +13.33%
Jul 08, 2020 slava yakubovich   43.62 Jul 31, 2020 @ 46.46 +6.51%
Mar 26, 2020 Mike Tomas   33.96 Apr 17, 2020 @ 37.59 +10.69%
Mar 23, 2020 Mike Tomas   23.43 Mar 25, 2020 @ 27.94 +19.25%
Feb 25, 2020 Masatake Miyoshi   46.50 Mar 20, 2020 @ 24.50 -47.31%
Jan 27, 2020 Andreas Schatz   42.09 Feb 21, 2020 @ 46.95 +11.55%
Jan 03, 2020 Big Bull   40.15 Jan 24, 2020 @ 42.77 +6.53%
Sep 25, 2019 田村 久明   34.18 Oct 18, 2019 @ 34.20 +0.06%
Aug 07, 2019 久野 泰史   34.83 Aug 07, 2019 @ 34.62 -0.60%
Jul 31, 2019 Robert Gysemans   42.75 Aug 23, 2019 @ 41.13 -3.79%
May 15, 2019 Jose Manuel Paredes...   48.15 Jun 07, 2019 @ 44.55 +7.48%
May 13, 2019 Charlie Choque   46.44 Jun 07, 2019 @ 44.55 -4.07%
May 07, 2019 Татьяна Причина   40.08 May 31, 2019 @ 42.66 -6.44%
Apr 29, 2019 Artur Odobesku   39.61 May 24, 2019 @ 45.06 -13.76%
Apr 08, 2019 久野 泰史   34.89 May 03, 2019 @ 38.11 +9.23%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SILK Comments

Write your thoughts about Silk Road Medical Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email